ループス腎炎:グローバル臨床試験レビューH1, 2014...市場調査レポートについてご紹介

【英文タイトル】Lupus Nephritis Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Lupus Nephritis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Lupus Nephritis to Immunology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Lupus Nephritis to Immunology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Lupus Nephritis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Lupus Nephritis Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Lupus Nephritis 33
Oct 15, 2013: Kadmon Announces Development Plans for Selective ROCK 2 Inhibitor, KD025, in Psoriasis, Lupus Nephritis and NASH 33
Jun 12, 2013: Teva And Active Biotech Report Positive Results From Phase IIa Study Of Laquinimod In Active Lupus Nephritis 33
Jun 28, 2012: Immune Tolerance Network Completes Enrollment Early For ACCESS Lupus Nephritis Study 34
Jun 03, 2010: CellCept Reached Positive Results In Phase III Trial In Lupus Nephritis 34
Jan 29, 2010: Bindarit A MCP-1/CCL2 Production Inhibitor 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Astellas Pharma Inc. 37
Clinical Trial Overview of Astellas Pharma Inc. 37
F. Hoffmann-La Roche Ltd. 38
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 38
Biogen Idec Inc. 39
Clinical Trial Overview of Biogen Idec Inc. 39
Anthera Pharmaceuticals‚ Inc. 40
Clinical Trial Overview of Anthera Pharmaceuticals‚ Inc. 40
Teva Pharmaceutical Industries Limited 41
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 41
La Jolla Pharmaceutical Company 42
Clinical Trial Overview of La Jolla Pharmaceutical Company 42
E. Merck KG 43
Clinical Trial Overview of E. Merck KG 43
Bristol-Myers Squibb Company 44
Clinical Trial Overview of Bristol-Myers Squibb Company 44
Aurinia Pharmaceuticals Inc. 45
Clinical Trial Overview of Aurinia Pharmaceuticals Inc. 45
Clinical Trial Overview of Top Institutes / Government 46
Nanjing University 46
Clinical Trial Overview of Nanjing University 46
National Institute of Arthritis and Musculoskeletal and Skin Diseases 47
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 47
Sun Yat-sen University 48
Clinical Trial Overview of Sun Yat-sen University 48
Faculty of Pharmaceutical Sciences, Chulalongkorn University 49
Clinical Trial Overview of Faculty of Pharmaceutical Sciences, Chulalongkorn University 49
Chinese University of Hong Kong 50
Clinical Trial Overview of Chinese University of Hong Kong 50
The National Institute of Allergy and Infectious Diseases 51
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 51
All India Institute of Medical Sciences 52
Clinical Trial Overview of All India Institute of Medical Sciences 52
The National Institute of Diabetes and Digestive and Kidney Diseases 53
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 53
Zhejiang University 54
Clinical Trial Overview of Zhejiang University 54
The Rogosin Institute 55
Clinical Trial Overview of The Rogosin Institute 55
Five Key Clinical Profiles 56
Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 95


【レポート販売概要】

■ タイトル:ループス腎炎:グローバル臨床試験レビューH1, 2014
■ 英文:Lupus Nephritis Global Clinical Trials Review, H1, 2014
■ 発行日:2014年1月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403163574
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。